-
CMS doubles down on Medicare drug price negotiations
17 Mar 2025 13:46 GMT
… , Breo Ellipta, Tradjenta, Xifaxan, Vraylar, Janumet, and Otezla to be included … negotiations aimed at reducing drug costs for Medicare beneficiaries.
On March 14 … about 14% of Medicare Part D's prescription drug costs, according …
-
Health Care Week in Review: HHS Releases Notice of Benefit and Payment Parameters for 2026 and CMS Identifies Drugs for Second Round of Medicare Price Negotiations
21 Jan 2025 03:58 GMT
… evidence available for specific medical treatments and technologies through a … the National Institute of Diabetes and Digestive and … its confirmatory trial delayed. OIG recommended FDA define specific …
JANUMET; JANUMET XR
Otezla
On January 15, 2025, the Drug …
-
Ozempic, Wegovy Among 15 Drugs Selected by HHS for Medicare Price Negotiations
17 Jan 2025 20:06 GMT
… next 15 drugs to undergo Medicare drug price negotiations with pharmaceutical companies, as … life-saving treatments at lower costs.”
The drugs up for … depressive disorder, and schizophrenia.
Janumet, Janumet XR: Diabetes drugs.
Otezla: Used for oral …
-
Q1 2025 Recap: Endocrinology News and Updates
01 Apr 2025 09:13 GMT
… Updates in Endocrinology
FDA Announces End to … (Janumet; Janumet XR). This marks the second round of Medicare drug … , Veru Pharmaceuticals announced positive Phase 2b trial results for … for treatment of chronic kidney disease and type 2 diabetes.
Diabetes …
-
Deutetrabenazine Among Notable Drugs Selected by Medicare to Lower Prescription Costs for Seniors
28 Jan 2025 21:07 GMT
… XR; Teva Pharmaceuticals), a medication for tardive dyskinesia … sitagliptin/metformin (Janumet; Janumet XR), and apremilast (Otezla … 15 Additional Drugs Selected for Medicare Drug Price Negotiations … FDA Approved as a One Pill, Once-Daily Treatment …
-
Cardiometabolic drugs consume majority of cost among those up for price negotiation
31 Jan 2025 20:34 GMT
… price negotiation for selected Medicare Part D drugs,” Mohammed Essa, MD, … , Janssen/Bayer), sitagliptin (Janumet/Janumet XR, Merck), empagliflozin (Jardiance, … as prevalence of heart failure, diabetes and atherosclerotic cardiovascular disease are …
-
Behind the Headlines: Sana’s Type 1 Diabetes Breakthrough, Drug Price Negotiations, and More
28 Jan 2025 00:05 GMT
… headlines from the pharmaceutical industry, including … Biotechnology’s early trial results showing that allogeneic treatment … medications listed encompassing a large percentage of overall drug … Tradjenta, Xifaxan, Vraylar, Janumet, Janumet XR, and Otezla. (3 …
-
Amid more drug-price scrutiny, biopharma companies largely keep their January hikes in check
29 Jan 2025 15:07 GMT
… nonprofit research group that compiles pharmaceutical pricing data. The Wall Street … the price of diabetes drug Mounjaro by 1% and obesity treatment Zepbound by … in decline, including Merck’s Janumet and Januvia at 42% and …
-
‘We applaud CMS’: Two more rheumatology drugs bound for Medicare price negotiation
29 Jan 2025 14:43 GMT
… statement. “Skipping medication doses or forgoing treatment can worsen their … metformin hydrochloride; sitagliptin phosphate (Janumet/Janumet XR, Merck);
palbociclib ( … Pharmaceuticals); and
semaglutide.
“The drugs treat conditions such as diabetes and …
-
Trump Executive Order Signals Drug Pricing Reforms Likely on the Horizon
28 Jan 2025 20:12 GMT
… Medicare Drug Price Negotiation Program granted the Centers for Medicare & Medicaid … for drugs that benefited from accelerated FDA … safety and efficacy trials post-approval.
CMMI … Janumet; Janumet XR; and (15) Otezla.
By announcing the new slate of drugs …